Lifecore Biomedical Inc. Total Liabilities
Lifecore Biomedical Inc. total liabilities. Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has total liabilities worth $213.41 Million USD as of May 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Lifecore Biomedical Inc. (LFCR) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Lifecore Biomedical Inc. (1996–2026)
Total liabilities of Lifecore Biomedical Inc. from 1996 to 2026. This chart illustrates how Lifecore Biomedical Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore Lifecore Biomedical Inc. (LFCR) investment intensity to see how much of total assets are deployed in long-term investments.
Lifecore Biomedical Inc. Competitors by Total Liabilities
The table below lists competitors of Lifecore Biomedical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chiang Mai Ram Medical Business Public Company Limited
BK:CMR
|
Thailand | ฿3.20 Billion |
|
Map Boga Adiperkasa Tbk PT
JK:MAPB
|
Indonesia | Rp1.35 Trillion |
|
Powerwell Holdings Bhd
KLSE:0217
|
Malaysia | RM68.20 Million |
|
Westwood Holdings Group Inc
NYSE:WHG
|
USA | $24.31 Million |
|
Surya Fajar Capital Tbk PT
JK:SFAN
|
Indonesia | Rp68.01 Billion |
|
Thai Nakarin Hospital Public Company Limited
BK:TNH
|
Thailand | ฿512.54 Million |
|
Texmaco Infrastructure & Holdings Limited
NSE:TEXINFRA
|
India | Rs-13.26 Billion |
Liability Composition Analysis (1996–2026)
This chart breaks down Lifecore Biomedical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Lifecore Biomedical Inc..
Liquidity & Leverage Metrics
Lifecore Biomedical Inc. Total Liabilities Ratios Explained
Lifecore Biomedical Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 13.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.93 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifecore Biomedical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifecore Biomedical Inc. (1996–2026)
The table below shows the annual total liabilities of Lifecore Biomedical Inc. from 1996 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-05-31 | $246.38 Million | +3.52% |
| 2025-05-31 | $238.01 Million | -1.91% |
| 2024-05-31 | $242.65 Million | +29.84% |
| 2023-05-31 | $186.88 Million | -0.18% |
| 2022-05-31 | $187.22 Million | -37.62% |
| 2021-05-31 | $300.14 Million | -3.26% |
| 2020-05-31 | $310.27 Million | +24.63% |
| 2019-05-31 | $248.95 Million | +63.63% |
| 2018-05-31 | $152.14 Million | +17.16% |
| 2017-05-31 | $129.86 Million | -0.96% |
| 2016-05-31 | $131.12 Million | +3.77% |
| 2015-05-31 | $126.36 Million | +16.07% |
| 2014-05-31 | $108.86 Million | -1.51% |
| 2013-05-31 | $110.53 Million | -12.37% |
| 2012-05-31 | $126.13 Million | +83.91% |
| 2011-05-31 | $68.59 Million | +1.28% |
| 2010-05-31 | $67.72 Million | +163.82% |
| 2009-05-31 | $25.67 Million | -25.75% |
| 2008-05-31 | $34.57 Million | +18.02% |
| 2007-05-31 | $29.30 Million | -9.04% |
| 2006-05-31 | $32.20 Million | +21.30% |
| 2005-05-31 | $26.55 Million | -11.23% |
| 2004-05-31 | $29.91 Million | -20.40% |
| 2003-05-31 | $37.57 Million | -25.25% |
| 2002-05-31 | $50.26 Million | -27.42% |
| 2001-05-31 | $69.25 Million | +3.77% |
| 2000-05-31 | $66.73 Million | +649.82% |
| 1999-05-31 | $8.90 Million | +2.30% |
| 1998-05-31 | $8.70 Million | -40.41% |
| 1997-05-31 | $14.60 Million | +711.11% |
| 1996-05-31 | $1.80 Million | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device … Read more